HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Yoshiji Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

10/2022Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis.
8/2022Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis.
4/2022Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosis.
3/2022ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.
1/2022Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
12/2021Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.
11/2021Association between Equol Production Status and Nonalcoholic Steatohepatitis.
10/2021Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis.
7/2021Evidence-based clinical practice guidelines for liver cirrhosis 2020.
1/2021Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Yoshiji Research Topics

Disease

70Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 07/2002
62Fibrosis (Cirrhosis)
10/2022 - 07/2002
48Hepatocellular Carcinoma (Hepatoma)
10/2022 - 04/2002
48Neoplasms (Cancer)
01/2022 - 03/2002
19Fatty Liver
10/2022 - 10/2006
15Alcoholic Fatty Liver
10/2022 - 06/2007
14Liver Diseases (Liver Disease)
05/2022 - 09/2004
13Infections
03/2022 - 05/2013
13Carcinogenesis
03/2020 - 07/2002
12Non-alcoholic Fatty Liver Disease
11/2021 - 10/2006
10Chronic Hepatitis C
10/2022 - 02/2005
10Ascites
05/2022 - 02/2017
9Hepatic Encephalopathy
03/2022 - 12/2017
9Inflammation (Inflammations)
12/2021 - 11/2009
9Insulin Resistance
08/2020 - 01/2009
8Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
03/2022 - 01/2017
7Hemorrhage
05/2022 - 11/2005
6Hyperammonemia
08/2022 - 12/2017
6Muscle Cramp (Cramp)
12/2020 - 12/2018
5Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2021 - 04/2011
5Chronic Hepatitis (Chronic Active Hepatitis)
01/2019 - 10/2004
4Liver Failure
10/2022 - 10/2011
4Sarcopenia
08/2022 - 01/2020
4Thrombosis (Thrombus)
06/2022 - 08/2017
4Thrombocytopenia (Thrombopenia)
01/2022 - 01/2006
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 08/2009
3Acute-On-Chronic Liver Failure
05/2022 - 05/2020
3Thrombophilia
03/2022 - 05/2019
3Pleural Effusion (Pleural Effusions)
03/2022 - 10/2002
3Edema (Dropsy)
03/2022 - 02/2018

Drug/Important Bio-Agent (IBA)

22Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 03/2002
22Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2012 - 03/2002
18InterferonsIBA
10/2022 - 02/2005
17Amino AcidsFDA Link
10/2022 - 07/2002
15Choline (Choline Chloride)IBA
10/2022 - 07/2002
15EndotoxinsIBA
05/2022 - 02/2010
14Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2002
13CDAA (Randox)IBA
10/2022 - 07/2002
13CytokinesIBA
08/2022 - 05/2006
10Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2003
10von Willebrand FactorIBA
04/2022 - 11/2006
10Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2010 - 03/2002
9Angiotensin IIIBA
12/2021 - 09/2003
9Messenger RNA (mRNA)IBA
01/2021 - 04/2002
9PerindoprilFDA LinkGeneric
11/2006 - 03/2002
8LipopolysaccharidesIBA
10/2022 - 08/2017
8Rifaximin (L 105)FDA Link
10/2022 - 12/2017
8EnzymesIBA
04/2022 - 07/2002
8Angiotensin II Type 1 Receptor BlockersIBA
01/2022 - 05/2009
8Losartan (Cozaar)FDA LinkGeneric
01/2022 - 05/2009
8Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2022 - 02/2016
8Antiviral Agents (Antivirals)IBA
01/2022 - 01/2017
8CollagenIBA
10/2020 - 07/2002
8Pharmaceutical PreparationsIBA
12/2019 - 02/2007
7Sorafenib (BAY 43-9006)FDA Link
10/2022 - 05/2012
7Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 06/2011
7Branched-Chain Amino AcidsIBA
12/2021 - 01/2009
7Glucose (Dextrose)FDA LinkGeneric
03/2020 - 01/2006
7Glutathione Transferase (Glutathione S-Transferase)IBA
06/2018 - 07/2003
6Toll-Like Receptor 4IBA
10/2022 - 11/2008
6TolvaptanFDA Link
05/2022 - 02/2017
6AntigensIBA
04/2022 - 06/2008
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 09/2017
6DiureticsIBA
01/2021 - 02/2017
6Therapeutic UsesIBA
12/2020 - 01/2003
6Tissue Inhibitor of Metalloproteinase-1IBA
11/2006 - 10/2002
5Serum AlbuminIBA
04/2022 - 01/2018
5Angiotensin Receptor AntagonistsIBA
12/2021 - 07/2011
5Transforming Growth Factor beta (TGF-beta)IBA
12/2016 - 05/2006
5Vitamin KFDA Link
05/2011 - 01/2007
4BilirubinIBA
05/2022 - 05/2012
4Carbon Tetrachloride (Tetrachloromethane)IBA
12/2021 - 01/2017
4Carrier Proteins (Binding Protein)IBA
10/2021 - 09/2017
4RNA (Ribonucleic Acid)IBA
07/2021 - 08/2005
4Interleukin-8 (Interleukin 8)IBA
06/2021 - 07/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2021 - 11/2008
4Prednisolone (Predate)FDA LinkGeneric
01/2021 - 01/2018
4Alanine Transaminase (SGPT)IBA
04/2020 - 11/2006
4Insulin (Novolin)FDA Link
04/2020 - 01/2006
4Ribavirin (Virazole)FDA LinkGeneric
01/2019 - 01/2006
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2017 - 03/2002
4AldosteroneIBA
08/2017 - 05/2010
4Vitamin K 2 (Vitamin K2)IBA
08/2009 - 03/2005
4Imatinib Mesylate (Gleevec)FDA Link
04/2009 - 05/2005
4Cyclin D1IBA
05/2005 - 03/2003
3SteroidsIBA
03/2022 - 05/2012
3AmmoniaIBA
03/2022 - 12/2018
3ZincIBA
03/2022 - 06/2021
3lusutrombopagIBA
01/2022 - 01/2020
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 06/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2006
3Bile Acids and Salts (Bile Acids)IBA
01/2022 - 11/2017
3lenvatinibIBA
01/2022 - 01/2021
3Vasopressins (Vasopressin)IBA
12/2021 - 11/2005
3AlbuminsIBA
10/2021 - 01/2017
3Hyaluronic Acid (Hyaluronan)IBA
10/2021 - 08/2020

Therapy/Procedure

43Therapeutics
05/2022 - 03/2002
10Drug Therapy (Chemotherapy)
01/2022 - 12/2014
8Oral Administration
10/2022 - 05/2005
6Chemoprevention
10/2014 - 11/2004